Keyphrases
% Response
12%
Clinical Scenarios
12%
Clinical Trial Design
12%
Clinical Trials
12%
Consensus Building
12%
Cyclophosphamide
12%
Design Effort
12%
Diagnostic Work-up
12%
Disease Management
12%
Disease Monitoring
12%
End-stage Renal Disease
12%
General Practice
12%
Glomerulonephritis
12%
Granulomatosis with Polyangiitis
100%
Group Membership
12%
Individual Preferences
12%
Listserv
12%
Maintenance Medication
12%
Maintenance Therapy
12%
Midwest
100%
Mycophenolate Mofetil
12%
Nephrologists
50%
Nephrology Practice
100%
Newly Diagnosed
12%
Pattern Similarity
12%
Pediatric
25%
Pediatric Nephrologist
12%
Pediatric Nephrology
100%
Pediatric Rheumatologist
12%
Pediatric Rheumatology
100%
Plasmapheresis
12%
Practice Characteristics
12%
Practice Patterns
100%
Practice Preferences
12%
Pulmonary Hemorrhage
12%
Rapidly Progressive Glomerulonephritis
12%
Rheumatologists
37%
Rheumatology
12%
Rheumatology Practice
100%
Rituximab
12%
Rituximab Plus Cyclophosphamide
12%
Survey Results
12%
Medicine and Dentistry
Clinical Trial
12%
Clinical Trial Design
12%
Cyclophosphamide
25%
Diseases
25%
End Stage Renal Disease
12%
General Medicine
12%
Glomerulonephritis
12%
Granulomatosis with Polyangiitis
100%
Maintenance Therapy
12%
Mycophenolate Mofetil
12%
Nephrologist
62%
Pediatric Nephrology
100%
Pediatric Rheumatology
100%
Pediatrics
37%
Plasmapheresis
12%
Pulmonary Hemorrhage
12%
Rapidly Progressive Glomerulonephritis
12%
Rheumatology
12%
Rituximab
25%